Stocksigma LogoStocksigma Logo

GlaxoSmithKline Pharmaceuticals Schedules Board Meeting for Q2 Results

GlaxoSmithKline Pharmaceuticals Limited will hold a Board of Directors meeting on 3rd Nov'26 to consider, approve, and take on record the un-audited

GlaxoSmithKline Pharmaceuticals Schedules Board Meeting for Q2 Results

GlaxoSmithKline Pharmaceuticals Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

GlaxoSmithKline Pharmaceuticals Schedules Board Meeting for Q2 Results GlaxoSmithKline Pharmaceuticals Limited will hold a Board of Directors meeting on 3rd Nov'26 to consider, approve, and take on record the un-audited financial results for the second quarter and half year ended 30th Sep'26, pursuant to Regulations 29 and 33 of SEBI LODR Regulations.

Original exchange filing (PDF)

More announcements from GlaxoSmithKline Pharmaceuticals Ltd

All GlaxoSmithKline Pharmaceuticals Ltd announcements